September 2024
1. LEI Y, Xu N, Niu C, Chen L, et al
   Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection.
   Virology. 2024;597:110142.
   

   >> Share

   
   
2. LIANG Z, Wang J, Zhang H, Gao L, et al
   Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
   Virology. 2024;597:110149.
   

   >> Share

   
   
3. DUDEK I, Czerkies M, Kwiatek A
   Differential expression of cytokines and elevated levels of MALAT1 - Long non-coding RNA in response to non-structural proteins of human respiratory syncytial virus.
   Virology. 2024;597:110127.
   

   >> Share

   
   August 2024
4. RZYMSKI P, Niedziela J, Poniedzialek B, Rosinska J, et al
   Humoral anti-SARS-CoV-2 response in patients with different long COVID phenotypes.
   Virology. 2024;596:110118.
   

   >> Share

   
   July 2024
5. CAI M, Wei Z, Hu X, Ji Y, et al
   The evolution, complexity, and diversity of swine influenza viruses in China: A hidden public health threat.
   Virology. 2024;598:110167.
   

   >> Share

   
   
6. LIU J, Ren T, Wang X, Wang H, et al
   The emergence, isolation, and phylogenetic analysis of a closely related human strain of parainfluenza virus 5 from a case of porcine reproductive and respiratory syndrome in China.
   Virology. 2024;597:110157.
   

   >> Share

   
   
7. LEE J, Naoe Y, Bang U, Nakagama Y, et al
   Neutralization sensitivity of SARS-CoV-2 Omicron variants FL.1 and GE.1 by therapeutic antibodies and XBB sera.
   Virology. 2024;595:110067.
   

   >> Share

   
   
8. GILLOT C, Tre-Hardy M, Cupaiolo R, Blairon L, et al
   Assessment of the neutralizing antibody response in Omicron breakthrough cases in healthcare workers who received the homologous booster of Moderna mRNA-1273.
   Virology. 2024;595:110082.
   

   >> Share

   
   
9. UENO S, Amarbayasgalan S, Sugiura Y, Takahashi T, et al
   Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
   Virology. 2024;595:110068.
   

   >> Share

   
   June 2024
10. ZHU H, Li X, Li X, Chen H, et al
    Protection against the H1N1 influenza virus using self-assembled nanoparticles formed by lumazine synthase and bearing the M2e peptide.
    Virology. 2024;597:110162.
    

    >> Share

    
    
11. NAVEED A, Yu J, Lawson S, Gao R, et al
    Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
    Virology. 2024;597:110138.
    

    >> Share

    
    
12. NGUYEN CT, Nakayama M, Ishigaki H, Kitagawa Y, et al
    Increased expression of CD38 on endothelial cells in SARS-CoV-2 infection in cynomolgus macaques.
    Virology. 2024;594:110052.
    

    >> Share

    
    
13. GE P, Ross TM
    COBRA HA and NA vaccination elicits long-live protective immune responses against pre-pandemic H2, H5, and H7 influenza virus subtypes.
    Virology. 2024;597:110119.
    

    >> Share

    
    May 2024
14. DUCATEZ MF, Wang C, Yang J, Zhao Y, et al
    Infection dynamics of subtype H9N2 low pathogenic avian influenza a virus in turkeys.
    Virology. 2024;596:110124.
    

    >> Share

    
    
15. TIAN Y, Deng Z, Chuai Z, Li C, et al
    A combination influenza mRNA vaccine candidate provided broad protection against diverse influenza virus challenge.
    Virology. 2024;596:110125.
    

    >> Share

    
    
16. BROGAARD L, Heegaard PMH, Larsen LE, Skovgaard K, et al
    Pulmonary MicroRNA expression after heterologous challenge with swine influenza A virus (H1N2) in immunized and non-immunized pigs.
    Virology. 2024;596:110117.
    

    >> Share

    
    
17. HUANG J, Ma K, Zhang J, Zhou J, et al
    Pathogenicity and transmission of novel highly pathogenic H7N2 variants originating from H7N9 avian influenza viruses in chickens.
    Virology. 2024;597:110121.
    

    >> Share

    
    
18. SAIKIA BK, Roy K, Konwar R
    Preliminary report on therapeutic potential of coal-derived carbon quantum dots against SARS-CoV-2 virus.
    Virology. 2024;593:110036.
    

    >> Share

    
    
19. LIU J, Gao L, Zhou N, Jiang Z, et al
    p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
    Virology. 2024;593:110018.
    

    >> Share

    
    April 2024
20. MA X, Wang Q, Xu X, Zhang W, et al
    miR-214-PTEN pathway is a potential mechanism for stress-induced immunosuppression affecting chicken immune response to avian influenza virus vaccine.
    Virology. 2024;595:110094.
    

    >> Share

    
    
21. KIM KH, Bhatnagar N, Subbiah J, Liu R, et al
    Cross-protection against influenza viruses by chimeric M2e-H3 stalk protein or multi-subtype neuraminidase plus M2e virus-like particle vaccine in ferrets.
    Virology. 2024;595:110097.
    

    >> Share

    
    
22. VALLERIANI F, Di Pancrazio C, Spedicato M, Di Teodoro G, et al
    A cell-adapted SARS-CoV-2 mutant, showing a deletion in the spike protein spanning the furin cleavage site, has reduced virulence at the lung level in K18-hACE2 mice.
    Virology. 2024;592:109997.
    

    >> Share

    
    
23. ALTINA NH, Maranon DG, Anderson JR, Donaldson MK, et al
    The leader RNA of SARS-CoV-2 sequesters polypyrimidine tract binding protein (PTBP1) and influences pre-mRNA splicing in infected cells.
    Virology. 2024;592:109986.
    

    >> Share

    
    March 2024
24. BRIGGS K, Chrzastek K, Segovia K, Mo J, et al
    Genetic insertion of mouse Myxovirus-resistance gene 1 increases innate resistance against both high and low pathogenic avian influenza virus by significantly decreasing replication in chicken DF1 cell line.
    Virology. 2024;595:110066.
    

    >> Share

    
    
25. SAKA N, Nishio M, Ohta K
    Human parainfluenza virus type 2 V protein inhibits mitochondrial apoptosis pathway through two ways.
    Virology. 2024;594:110053.
    

    >> Share

    
    
26. ZHENG X, Yang R, Zhao Y, Zhang Y, et al
    Alum/CpG adjuvant promotes immunogenicity of inactivated SARS-CoV-2 Omicron vaccine through enhanced humoral and cellular immunity.
    Virology. 2024;594:110050.
    

    >> Share

    
    
27. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
    Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
    Virology. 2024;591:109985.
    

    >> Share

    
    February 2024
28. HUANG Y, Zhang P, Han S, Hu B, et al
    Effect of Enteromorpha polysaccharides on gut-lung axis in mice infected with H5N1 influenza virus.
    Virology. 2024;593:110031.
    

    >> Share

    
    
29. MA B, Tao M, Li Z, Zheng Q, et al
    Mucosal vaccines for viral diseases: Status and prospects.
    Virology. 2024;593:110026.
    

    >> Share

    
    
30. YANG J, Lan R, Chang H, Li H, et al
    Isolation and characterization of genotype 4 Eurasian avian-like H1N1 influenza virus in pigs suffering from pneumonia.
    Virology. 2024;592:110009.
    

    >> Share

    
    
31. LEE DW, Kim JM, Kim DW, Kim JY, et al
    Three distinct ORF1a recombinants of the SARS-CoV-2 Delta variant of concern.
    Virology. 2024;590:109945.
    

    >> Share

    
    January 2024
32. FANG K, Song W, Zhang Y, Zheng Y, et al
    Comparative analysis and prediction of avian influenza in Shangrao city, China from 2016 to 2022.
    Virology. 2024;592:109995.
    

    >> Share

    
    
33. YUAN F, Yang L, Hsiao SH, Herndon NL, et al
    A neonatal piglet model reveals interactions between nasal microbiota and influenza A virus pathogenesis.
    Virology. 2024;592:109996.
    

    >> Share

    
    
34. ZHANG Y, Wang D, Xiang Q, Hu X, et al
    A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein.
    Virology. 2024;589:109925.
    

    >> Share

    
    December 2023
35. TANG C, Carrera Montoya J, Fritzlar S, Flavel M, et al
    Polyphenol rich sugarcane extract (PRSE) has potential antiviral activity against influenza A virus in vitro.
    Virology. 2023;590:109969.
    

    >> Share

    
    
36. BIALY D, Richardson S, Chrzastek K, Bhat S, et al
    Recombinant A(H6N1)-H274Y avian influenza virus with dual drug resistance does not require permissive mutations to retain the replicative fitness in vitro and in ovo.
    Virology. 2023;590:109954.
    

    >> Share

    
    November 2023
37. RAMEY AM, Scott LC, Ahlstrom CA, Buck EJ, et al
    Molecular detection and characterization of highly pathogenic H5N1 clade 2.3.4.4b avian influenza viruses among hunter-harvested wild birds provides evidence for three independent introductions into Alaska.
    Virology. 2023;589:109938.
    

    >> Share

    
    
38. ZHU M, Zeng H, He J, Zhu Y, et al
    Reassortant H9N2 canine influenza viruses containing the pandemic H1N1/2009 ribonucleoprotein complex circulating in pigs acquired enhanced virulence in mice.
    Virology. 2023;589:109927.
    

    >> Share

    
    
39. NAIQING X, Tang X, Wang X, Cai M, et al
    Hemagglutinin affects replication, stability and airborne transmission of the H9N2 subtype avian influenza virus.
    Virology. 2023;589:109926.
    

    >> Share

    
    October 2023
40. AFRIN SZ, Sathi FA, Nooruzzaman M, Parvin R, et al
    Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
    Virology. 2023;587:109882.
    

    >> Share

    
    September 2023
41. BRIGGS K, Sweeney R, Blehert DS, Spackman E, et al
    SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro.
    Virology. 2023;586:122-129.
    

    >> Share

    
    
42. RAMIREZ KA, Mond J, Papenburg J, Boivin G, et al
    In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.
    Virology. 2023;586:115-121.
    

    >> Share

    
    
43. XIAO Y, Wang L, Fang SS, Luo F, et al
    Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo.
    Virology. 2023;586:105-114.
    

    >> Share

    
    August 2023
44. TEWARI DN, Biswas A, Chakrabarti AK, Dutta S, et al
    AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.
    Virology. 2023;587:109875.
    

    >> Share

    
    
45. UPRETY T, Sreenivasan CC, Thomas M, Hause B, et al
    Prevalence and characterization of seven-segmented influenza viruses in bovine respiratory disease complex.
    Virology. 2023;587:109859.
    

    >> Share

    
    
46. YOUK S, Torchetti MK, Lantz K, Lenoch JB, et al
    H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021-April 2022.
    Virology. 2023;587:109860.
    

    >> Share

    
    
47. MARANO JM, Cereghino C, Finkielstein CV, Weger-Lucarelli J, et al
    An in vitro workflow to create and modify infectious clones using replication cycle reaction.
    Virology. 2023;585:109-116.
    

    >> Share

    
    
48. SILVA JUNIOR JVJ, Duraes-Carvalho R, de Souza JR, Ramos Janini LM, et al
    Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
    Virology. 2023;585:78-81.
    

    >> Share

    
    July 2023
49. ZHOU H, Liu J, Li L, Sun J, et al
    Circulation of influenza C virus of C/Sao Paulo/378/82 lineage among pediatric acute respiratory cases, Shandong, China.
    Virology. 2023;587:109855.
    

    >> Share

    
    June 2023
50. TANG L, Liu X, Wang C, Shu C, et al
    USP18 promotes innate immune responses and apoptosis in influenza A virus-infected A549 cells via cGAS-STING pathway.
    Virology. 2023;585:240-247.
    

    >> Share

    
    
51. SU R, Shi Z, Li E, Zhu M, et al
    A Trim-RBD-GEM vaccine candidate protects mice from SARS-CoV-2.
    Virology. 2023;585:145-154.
    

    >> Share

    
    
52. YILMAZ B, Cakmak Genc G, Karakas Celik S, Piskin N, et al
    The 3'UTR region of the DNA repair gene PARP-1 May increase the severity of COVID-19 by altering the binding of antiviral miRNAs.
    Virology. 2023;583:29-35.
    

    >> Share

    
    
53. POTTAGE T, Onianwa O, Atkinson B, Spencer A, et al
    Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature.
    Virology. 2023;583:27-28.
    

    >> Share

    
    
54. PFANZAGL B
    The ICAM-1 ligand HRV-A89 is internalized independently of clathrin-mediated endocytosis and its capsid reaches late endosomes.
    Virology. 2023;583:45-51.
    

    >> Share

    
    May 2023
55. CHENCHULA S, Amerneni KC, Ghanta MK, Padmavathi R, et al
    Clinical virology and effect of Covid-19 vaccination and monoclonal antibodies against highly infectious SARS- CoV-2 omicron sub variant BF.7 (BA.5.2.1.7): A systematic review.
    Virology. 2023;584:38-43.
    

    >> Share

    
    
56. SUN X, Belser JA, Kieran TJ, Brock N, et al
    Enhanced fitness of SARS-CoV-2 B.1.617.2 Delta variant in ferrets.
    Virology. 2023;582:57-61.
    

    >> Share

    
    
57. MAYER AM, Grohs Ferrareze PA, de Oliveira LFV, Gregianini TS, et al
    Genomic characterization and molecular evolution of SARS-CoV-2 in Rio Grande do Sul State, Brazil.
    Virology. 2023;582:1-11.
    

    >> Share

    
    April 2023
58. BOSCO-LAUTH A, Rodriguez A, Maison RM, Porter SM, et al
    H7N9 influenza A virus transmission in a multispecies barnyard model.
    Virology. 2023;582:100-105.
    

    >> Share

    
    
59. KANDWAL S, Fayne D
    Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks.
    Virology. 2023;581:97-115.
    

    >> Share

    
    March 2023
60. HUONG TN, Ravi Iyer L, Lui J, Wang Y, et al
    The respiratory syncytial virus SH protein is incorporated into infectious virus particles that form on virus-infected cells.
    Virology. 2023;580:28-40.
    

    >> Share

    
    December 2022
61. VILLA R, Renzi S, Dotti S, Lucchini F, et al
    siRNAs pools generated in Escherichia coli exhibit strong RNA-interference activity against influenza virus genomic sequences.
    Virology. 2022;579:38-45.
    

    >> Share

    
    
62. TARE DS, Pawar SD, Keng SS, Kode SS, et al
    The evolution, characterization and phylogeography of avian influenza H9N2 viruses from India.
    Virology. 2022;579:9-28.
    

    >> Share

    
    
63. DEHGANI-MOBARAKI P, Wang C, Floridi A, Floridi E, et al
    Long-term persistence of IgG antibodies in recovered COVID-19 individuals at 18 months post-infection and the impact of two-dose BNT162b2 (Pfizer-BioNTech) mRNA vaccination on the antibody response: Analysis using fixed-effects linear regression model
    Virology. 2022;578:111-116.
    

    >> Share

    
    November 2022
64. HIONO T, Kobayashi D, Kobayashi A, Suzuki T, et al
    Virological, pathological, and glycovirological investigations of an Ezo red fox and a tanuki naturally infected with H5N1 high pathogenicity avian influenza viruses in Hokkaido, Japan.
    Virology. 2022;578:35-44.
    

    >> Share

    
    
65. FIGUEIREDO-NUNES I, Trigueiro-Louro J, Rebelo-de-Andrade H
    Exploring new antiviral targets for influenza and COVID-19: Mapping promising hot spots in viral RNA polymerases.
    Virology. 2022;578:45-60.
    

    >> Share

    
    
66. SANTOS LA, Almeida F, Giria M, Trigueiro-Louro J, et al
    Adaptive evolution of PB1 from influenza A(H1N1)pdm09 virus towards an enhanced fitness.
    Virology. 2022;578:1-6.
    

    >> Share

    
    October 2022
67. LIANG Y, Hjulsager CK, Seekings AH, Warren CJ, et al
    Pathogenesis and infection dynamics of high pathogenicity avian influenza virus (HPAIV) H5N6 (clade 2.3.4.4b) in pheasants and onward transmission to chickens.
    Virology. 2022;577:138-148.
    

    >> Share

    
    
68. LAMICHHANE P, Schmidt ME, Terhuja M, Varga SM, et al
    A live single-cycle RSV vaccine expressing prefusion F protein.
    Virology. 2022;577:51-64.
    

    >> Share

    
    
69. TANIKAWA T, Fujii K, Sugie Y, Tsunekuni R, et al
    Ubiquitin-specific protease 18 in mallard (Anas platyrhynchos) interferes with type I interferon-mediated inhibition of high pathogenicity avian influenza virus replication.
    Virology. 2022;577:32-42.
    

    >> Share

    
    
70. BRAKEL KA, Ma Y, Binjawadagi R, Harder O, et al
    Codon-optimization of the respiratory syncytial virus (RSV) G protein expressed in a vesicular stomatitis virus (VSV) vector improves immune responses in a cotton rat model.
    Virology. 2022;575:101-110.
    

    >> Share

    
    
71. AMIDEI A, Dobrovolny HM
    Estimation of virus-mediated cell fusion rate of SARS-CoV-2.
    Virology. 2022;575:91-100.
    

    >> Share

    
    
72. MONTEIRO A, Chang AJ, Welliver RR, Baron S, et al
    Humoral cross-coronavirus responses against the S2 region in children with Kawasaki disease.
    Virology. 2022;575:83-90.
    

    >> Share

    
    
73. POPOVIC M
    Strain wars 4 - Darwinian evolution through Gibbs' glasses: Gibbs energies of binding and growth explain evolution of SARS-CoV-2 from Hu-1 to BA.2.
    Virology. 2022;575:36-42.
    

    >> Share

    
    September 2022
74. TANG CY, Boftsi M, Staudt L, McElroy JA, et al
    SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season.
    Virology. 2022;576:105-110.
    

    >> Share

    
    
75. WANG R, Huang X, Cao T, Sun C, et al
    Development of a thermostable SARS-CoV-2 variant-based bivalent protein vaccine with cross-neutralizing potency against Omicron subvariants.
    Virology. 2022;576:61-68.
    

    >> Share

    
    
76. YAN H, Liu Z, Yan G, Liu X, et al
    A robust high-throughput fluorescence polarization assay for rapid screening of SARS-CoV-2 papain-like protease inhibitors.
    Virology. 2022;574:18-24.
    

    >> Share

    
    August 2022
77. ABDELKADER A, Elzemrany AA, El-Nadi M, Elsabbagh SA, et al
    In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing.
    Virology. 2022;573:96-110.
    

    >> Share

    
    
78. AL-ZYOUD W, Haddad H
    Potential linear B-cells epitope change to a helix structure in the spike of Omicron 21L or BA.2 predicts increased SARS-CoV-2 antibodies evasion.
    Virology. 2022;573:84-95.
    

    >> Share

    
    July 2022
79. WANG T, Wei F, Jiang Z, Song J, et al
    Influenza virus NS1 interacts with 14-3-3epsilon to antagonize the production of RIG-I-mediated type I interferons.
    Virology. 2022;574:47-56.
    

    >> Share

    
    
80. HAN M, Gao S, Hu W, Zhou Q, et al
    Inhibitory effects of cedar pine needle extract on H9N2 avian influenza virus in vitro and in vivo.
    Virology. 2022;574:25-36.
    

    >> Share

    
    
81. GE Y, Liu K, Chi Y, Zhu X, et al
    Exosomal microRNA expression profiles derived from A549 human lung cells in response to influenza A/H1N1pdm09 infection.
    Virology. 2022;574:9-17.
    

    >> Share

    
    
82. OH J, Subbiah J, Kim KH, Park BR, et al
    Impact of hemagglutination activity and M2e immunity on conferring protection against influenza viruses.
    Virology. 2022;574:37-46.
    

    >> Share

    
    
83. KUMAR P, Mathayan M, Smieszek SP, Przychodzen BP, et al
    Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection.
    Virology. 2022;572:64-71.
    

    >> Share

    
    
84. PONDE RAA
    Physicochemical effect of the N501Y, E484K/Q, K417N/T, L452R and T478K mutations on the SARS-CoV-2 spike protein RBD and its influence on agent fitness and on attributes developed by emerging variants of concern.
    Virology. 2022;572:44-54.
    

    >> Share

    
    June 2022
85. GUAN M, Jacobson O, Sarafianos G, Baroch J, et al
    Exposure of white-tailed deer in North America to influenza D virus.
    Virology. 2022;573:111-117.
    

    >> Share

    
    
86. LIM H, Kim SE, Lee YH, Hwang YH, et al
    Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein.
    Virology. 2022;573:118-123.
    

    >> Share

    
    
87. ZHU Y, Scholle F, Kisthardt SC, Xie DY, et al
    Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229E.
    Virology. 2022;571:21-33.
    

    >> Share

    
    May 2022
88. KHAN K, Khan SA, Jalal K, Ul-Haq Z, et al
    Immunoinformatic approach for the construction of multi-epitopes vaccine against omicron COVID-19 variant.
    Virology. 2022;572:28-43.
    

    >> Share

    
    
89. ZMASEK CM, Lefkowitz EJ, Niewiadomska A, Scheuermann RH, et al
    Genomic evolution of the Coronaviridae family.
    Virology. 2022;570:123-133.
    

    >> Share

    
    
90. POPOVIC M
    Strain wars 2: Binding constants, enthalpies, entropies, Gibbs energies and rates of binding of SARS-CoV-2 variants.
    Virology. 2022;570:35-44.
    

    >> Share

    
    
91. EL-ASHREY MK, Bakr RO, Fayed MAA, Refaey RH, et al
    Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease.
    Virology. 2022;570:18-28.
    

    >> Share

    
    April 2022
92. PUCHINGER K, Castelletti N, Rubio-Acero R, Geldmacher C, et al
    The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 - Results from a prospective cohort of outpatient COVID-19 cases.
    Virology. 2022;569:37-43.
    

    >> Share

    
    
93. MI T, Wang T, Xu H, Sun P, et al
    Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants.
    Virology. 2022;569:56-63.
    

    >> Share

    
    
94. SARKAR L, Oko L, Gupta S, Bubak AN, et al
    Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict beta-coronaviral infection and replication.
    Virology. 2022;569:13-28.
    

    >> Share

    
    
95. KAPCZYNSKI DR, Sweeney R, Spackman E, Pantin-Jackwood M, et al
    Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells.
    Virology. 2022;569:1-12.
    

    >> Share

    
    March 2022
96. MOGRO EG, Bottero D, Lozano MJ
    Analysis of SARS-CoV-2 synonymous codon usage evolution throughout the COVID-19 pandemic.
    Virology. 2022;568:56-71.
    

    >> Share

    
    
97. XU H, Akinyemi IA, Chitre SA, Loeb JC, et al
    SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway.
    Virology. 2022;568:13-22.
    

    >> Share

    
    February 2022
98. CHEN X, Sun HY, Lee CY, Rostad CA, et al
    Functional antibody-dependent cell mediated cytotoxicity (ADCC) responses to vaccine and circulating influenza strains following vaccination.
    Virology. 2022;569:44-55.
    

    >> Share

    
    January 2022
99. CHEN Z, Zeng Y, Wei Y, Wang Q, et al
    Influenza D virus Matrix protein 1 restricts the type I interferon response by degrading TRAF6.
    Virology. 2022;568:1-11.
    

    >> Share

    
    
100. AFRIN SZ, Islam MT, Paul SK, Kobayashi N, et al
     Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021.
     Virology. 2022;565:29-37.
     

     >> Share

     
     
101. SODERLUND-VENERMO M, Varma A, Guo D, Gladue DP, et al
     World Society for Virology first international conference: Tackling global virus epidemics.
     Virology. 2022;566:114-121.
     

     >> Share

     
     
102. NADERI N, Rahimzadeh M
     Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.
     Virology. 2022;566:106-113.
     

     >> Share

     
     
103. RAYMONDA MH, Ciesla JH, Monaghan M, Leach J, et al
     Pharmacologic profiling reveals lapatinib as a novel antiviral against SARS-CoV-2 in vitro.
     Virology. 2022;566:60-68.
     

     >> Share

     
     
104. KUMAR P, Bhardwaj T, Garg N, Giri R, et al
     Microsecond simulations and CD spectroscopy reveals the intrinsically disordered nature of SARS-CoV-2 spike-C-terminal cytoplasmic tail (residues 1242-1273) in isolation.
     Virology. 2022;566:42-55.
     

     >> Share

     
     December 2021
105. PARK BR, Subbiah J, Kim KH, Kwon YM, et al
     Enhanced cross protection by hetero prime-boost vaccination with recombinant influenza viruses containing chimeric hemagglutinin-M2e epitopes.
     Virology. 2021;566:143-152.
     

     >> Share

     
     
106. HEINIMAKI S, Lampinen V, Tamminen K, Hankaniemi MM, et al
     Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology.
     Virology. 2021;566:89-97.
     

     >> Share

     
     
107. HU Z, Chen JP, Xu JC, Chen ZY, et al
     A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination.
     Virology. 2021;566:56-59.
     

     >> Share

     
     November 2021
108. TRIGUEIRO-LOURO J, Santos LA, Almeida F, Correia V, et al
     NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.
     Virology. 2021;565:106-116.
     

     >> Share

     
     
109. GONG SY, Chatterjee D, Richard J, Prevost J, et al
     Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity.
     Virology. 2021;563:134-145.
     

     >> Share

     
     
110. RAI P, Chuong C, LeRoith T, Smyth JW, et al
     Adenovirus transduction to express human ACE2 causes obesity-specific morbidity in mice, impeding studies on the effect of host nutritional status on SARS-CoV-2 pathogenesis.
     Virology. 2021;563:98-106.
     

     >> Share

     
     
111. ABDELHAFIZ AS, Fouad MA, Sayed-Ahmed MM, Kamel MM, et al
     Upregulation of FOXP3 is associated with severity of hypoxia and poor outcomes in COVID-19 patients.
     Virology. 2021;563:74-81.
     

     >> Share

     
     
112. HARDER OE, Martinez M, Niewiesk S
     Nonsteroidal anti-inflammatory drugs restore immune function to respiratory syncytial virus in geriatric cotton rats (Sigmodon hispidus).
     Virology. 2021;563:28-37.
     

     >> Share

     
     October 2021
113. AHMED SM, Nasr MA, Elshenawy SE, Hussein AE, et al
     BCG vaccination and the risk of COVID 19: A possible correlation.
     Virology. 2021;565:73-81.
     

     >> Share

     
     
114. ZHANG G, Ng F, Chen M
     Short-hairpin RNAs delivered by recombinant adeno-associated virus inhibited the replication of influenza A viruses in vitro.
     Virology. 2021;564:46-52.
     

     >> Share

     
     
115. BYRD-LEOTIS L, Lasanajak Y, Bowen T, Baker K, et al
     SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
     Virology. 2021;562:142-148.
     

     >> Share

     
     
116. TAGHIZADEH P, Salehi S, Heshmati A, Houshmand SM, et al
     Study on SARS-CoV-2 strains in Iran reveals potential contribution of co-infection with and recombination between different strains to the emergence of new strains.
     Virology. 2021;562:63-73.
     

     >> Share

     
     
117. DEUTSCHMANN-OLEK KM, Yue WW, Bezerra GA, Skern T, et al
     Defining substrate selection by rhinoviral 2A proteinase through its crystal structure with the inhibitor zVAM.fmk.
     Virology. 2021;562:128-141.
     

     >> Share

     
     September 2021
118. WELCH M, Park J, Harmon K, Zhang J, et al
     Pathogenesis of a novel porcine parainfluenza virus type 1 isolate in conventional and colostrum deprived/caesarean derived pigs.
     Virology. 2021;563:88-97.
     

     >> Share

     
     
119. VERMA J, Subbarao N
     Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability.
     Virology. 2021;561:107-116.
     

     >> Share

     
     
120. PLAAS M, Seppa K, Gaur N, Kasenomm P, et al
     Age- and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia.
     Virology. 2021;561:65-68.
     

     >> Share

     
     August 2021
121. MENNE Z, Pliasas VC, Compans RW, Glover S, et al
     Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.
     Virology. 2021;562:197-208.
     

     >> Share

     
     
122. NAEMI FMA, Al-Adwani S, Al-Khatabi H, Al-Nazawi A, et al
     Frequency of HLA alleles among COVID-19 infected patients: Preliminary data from Saudi Arabia.
     Virology. 2021;560:1-7.
     

     >> Share

     
     July 2021
123. CHEN X, Rostad CA, Anderson LJ, Sun HY, et al
     The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein.
     Virology. 2021;559:1-9.
     

     >> Share

     
     June 2021
124. ICHIMIYA T, Okamatsu M, Kinoshita T, Kobayashi D, et al
     Sulfated glycans containing NeuAcalpha2-3Gal facilitate the propagation of human H1N1 influenza A viruses in eggs.
     Virology. 2021;562:29-39.
     

     >> Share

     
     
125. UEDA H, Yamakawa N, Takeuchi K
     Amino- and carboxyl-terminal ends of the bovine parainfluenza virus type 3 matrix protein are important for virion and virus-like particle release.
     Virology. 2021;561:17-27.
     

     >> Share

     
     
126. SUN H, Liu J, Xiao Y, Duan Y, et al
     Pathogenicity of novel reassortant Eurasian avian-like H1N1 influenza virus in pigs.
     Virology. 2021;561:28-35.
     

     >> Share

     
     
127. TERRY JS, Anderson LB, Scherman MS, McAlister CE, et al
     Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.
     Virology. 2021;558:28-37.
     

     >> Share

     
     
128. NAYAK K, Gottimukkala K, Kumar S, Reddy ES, et al
     Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.
     Virology. 2021;558:13-21.
     

     >> Share

     
     May 2021
129. CASE JB, Winkler ES, Errico JM, Diamond MS, et al
     On the road to ending the COVID-19 pandemic: Are we there yet?
     Virology. 2021;557:70-85.
     

     >> Share

     
     
130. DJUKIC T, Mladenovic M, Stanic-Vucinic D, Radosavljevic J, et al
     Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
     Virology. 2021;557:15-22.
     

     >> Share

     
     April 2021
131. UPRETY T, Sreenivasan CC, Bhattarai S, Wang D, et al
     Isolation and development of bovine primary respiratory cells as model to study influenza D virus infection.
     Virology. 2021;559:89-99.
     

     >> Share

     
     
132. WATERS K, Wan HJ, Han L, Xue J, et al
     Variations outside the conserved motifs of PB1 catalytic active site may affect replication efficiency of the RNP complex of influenza A virus.
     Virology. 2021;559:145-155.
     

     >> Share

     
     
133. NOLAN KE, Baer LA, Karekar P, Nelson AM, et al
     Metabolic shifts modulate lung injury caused by infection with H1N1 influenza A virus.
     Virology. 2021;559:111-119.
     

     >> Share

     
     
134. STAUFT CB, Lien CZ, Selvaraj P, Liu S, et al
     The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
     Virology. 2021;556:96-100.
     

     >> Share

     
     
135. DETSIKA MG, Ampelakiotou K, Grigoriou E, Psarra K, et al
     A novel ratio of CD8(+):B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome.
     Virology. 2021;556:79-86.
     

     >> Share

     
     
136. ZHIRNOV OP, Chlanda P
     The cleavage of spike protein capital EN, Cyrilliccapital A, Cyrillic0-->capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus.
     Virology. 2021;559:86-88.
     

     capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus.&body=ZHIRNOV OP, Chlanda P. The cleavage of spike protein capital EN, Cyrilliccapital A, Cyrillic0-->capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus. Virology. 2021;559:86-88. https://www.ncbi.nlm.nih.gov/m/pubmed/33845247" ALT="Email" TITLE="Email"> --> >> Share

     
     March 2021
137. SEEKINGS AH, Warren CJ, Thomas SS, Mahmood S, et al
     Highly pathogenic avian influenza virus H5N6 (clade 2.3.4.4b) has a preferable host tropism for waterfowl reflected in its inefficient transmission to terrestrial poultry.
     Virology. 2021;559:74-85.
     

     >> Share

     
     
138. WOLF JJ, Xia C, Studstill CJ, Ngo H, et al
     Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response.
     Virology. 2021;558:67-75.
     

     >> Share

     
     
139. XIE L, Yi K, Li Y
     SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.
     Virology. 2021;558:22-27.
     

     >> Share

     
     
140. LU KT, Yamamoto T, McDonald D, Li W, et al
     U.S.-Japan cooperative medical sciences program: 22nd International Conference on Emerging Infectious Diseases in the Pacific Rim.
     Virology. 2021;555:71-77.
     

     >> Share

     
     
141. TAKESHITA M, Nishina N, Moriyama S, Takahashi Y, et al
     Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
     Virology. 2021;555:35-43.
     

     >> Share

     
     February 2021
142. NOMURA N, Matsuno K, Shingai M, Ohno M, et al
     Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis.
     Virology. 2021;557:55-61.
     

     >> Share

     
     
143. ABDEL-MONEIM AS, Abdelwhab EM, Memish ZA
     Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.
     Virology. 2021;558:1-12.
     

     >> Share

     
     
144. ISHIGAKI H, Nakayama M, Kitagawa Y, Nguyen CT, et al
     Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
     Virology. 2021;554:97-105.
     

     >> Share

     
     
145. REFAEY RH, El-Ashrey MK, Nissan YM
     Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study.
     Virology. 2021;554:48-54.
     

     >> Share

     
     January 2021
146. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
     Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.
     Virology. 2021;553:154-156.
     

     >> Share

     
     December 2020
147. MORE SA, Patil AS, Sakle NS, Mokale SN, et al
     Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
     Virology. 2020;555:10-18.
     

     >> Share

     
     
148. LI L, Liang Y, Hu F, Yan H, et al
     Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
     Virology. 2020;551:26-35.
     

     >> Share

     
     
149. JIANG RD, Li B, Liu XL, Liu MQ, et al
     Bat mammalian orthoreoviruses cause severe pneumonia in mice.
     Virology. 2020;551:84-92.
     

     >> Share

     
     November 2020
150. YU R, Tan S, Dan Y, Lu Y, et al
     Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection.
     Virology. 2020;553:131-134.
     

     >> Share

     
     
151. POWELL JD, Abente EJ, Chang J, Souza CK, et al
     Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.
     Virology. 2020;553:94-101.
     

     >> Share

     
     
152. JONES LR, Manrique JM
     Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.
     Virology. 2020;550:70-77.
     

     >> Share

     
     
153. DOBROVOLNY HM
     Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
     Virology. 2020;550:61-69.
     

     >> Share

     
     
154. KISHKO M, Catalan J, Swanson K, DiNapoli J, et al
     Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
     Virology. 2020;550:21-26.
     

     >> Share

     
     September 2020
155. NISSLY RH, Zaman N, Ibrahim PAS, McDaniel K, et al
     Influenza C and D viral load in cattle correlates with bovine respiratory disease (BRD): Emerging role of orthomyxoviruses in the pathogenesis of BRD.
     Virology. 2020;551:10-15.
     

     >> Share

     
     
156. SEYED HOSSEINI E, Riahi Kashani N, Nikzad H, Azadbakht J, et al
     The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.
     Virology. 2020;551:1-9.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share